Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Onyx

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Onyx's 2012 oncology sales performance.

Onyx Pharmaceuticals, Inc.

Takeda's 'oral Velcade' clears first phase III hurdle

Takeda's 'oral Velcade' clears first phase III hurdle Since 2012 Velcade has faced competition from Amgen and Onyx' fast-growing injectable rival Kyprolis (carfilzomib), which saw sales reach $331m last year, four times the level achieved in the prior ... Moreover, with some phase III data in hand, Takeda's

Onyx Health appoints Dean Forbes

Onyx Health appoints Dean Forbes He moves from Pharma Nord. Healthcare communications agency Onyx Health has appointed Dean Forbes to support business development as client account manager. ... He now makes the switch to agency at Onyx where he will develop relationships with key

Amgen banking on three launches in 2015

Amgen banking on three launches in 2015 in the first full-year since Amgen acquired the drug as part of its $10.4bn acquisition of Onyx Pharmaceuticals in 2013.

New ASPIRE data boosts Amgen's Kyprolis

New ASPIRE data boosts Amgen's Kyprolis Kyprolis was one of the drivers behind Amgen's $10.4bn acquisition of Onyx last year and - while it has been growing steadily since its launch in 2012 with sales of

Amgen hit as Kyprolis fails myeloma study

Amgen hit as Kyprolis fails myeloma study The company's Onyx Pharmaceuticals subsidiary revealed yesterday that Kyprolis (carfilzomib) was unable to improve overall survival in the FOCUS study, which compared the drug to steroid therapy and cyclophosphamide in ... Amgen's takeover of Onyx was

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...